Stalevo®-associated lymphocytic colitis;Colite lymphocytaire associée à la prise de Stalevo®

Gastroenterologie Clinique et Biologique

Volumn 32, Issue 8-9, 2008, Pages 698-699

  Lim, C ^a   Macaigne, G ^a   Boivin, J F ^a   Auriaul, M L ^a   Deplus, R ^a  

^a Centre hospitalier de Lagny Marne la Vallee   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ATORVASTATIN; CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; PIRIBEDIL;

ABDOMINAL PAIN; ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; CONSULTATION; DIARRHEA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; LETTER; LYMPHOCYTIC COLITIS; MALE; PARKINSON DISEASE; SIGMOIDOSCOPY;

CARBIDOPA; CATECHOLS; COLITIS, LYMPHOCYTIC; DRUG COMBINATIONS; HUMANS; LEVODOPA; MALE; MIDDLE AGED;

EID: 51449113478     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2008.02.006     Document Type: Letter

References (5)

1. Schneider S., Rampal A., Hebuterne X., and Rampal P. Les colites microscopiques. Gastroenterol Clin Biol 22 (1998) 431-441
2. Rassiat E., Michiels C., Sgro C., Yaziji N., Piard F., and Faivre J. Lymphocytic colitis du to Modopar. Gastroenterol Clin Biol 24 8-9 (2000) 852-853
3. Bégaud B., Evreux J.C., Jouglard J., and Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Therapie 40 (1985) 111-118
4. Beaugerie L., Luboinski J., Brousse N., et al. Drug-induced lymphocytic colitis. Gut 35 (1994) 426-428
5. Baert F., Wouters K., D'Haens G., Hoang P., Naegels S., D'Heygere F., et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 45 (1999) 375-381